NEWS
HOMENEWS
- 2025.04.08Veritas In Silico to Announce Financial Results for the First Quarter of FY2025 on May 9
- 2025.03.12(Scheduled for Apr. 15) Invited Lecture: Using AI for mRNA-Targeted Small Molecule Drug Discovery – Our CSO to Present at the 20th Annual Drug Discovery Chemistry Conference
- 2025.02.18(Scheduled for Mar. 28) Representative Nakamura to Present at the 105th CSJ Annual Meeting
- 2025.01.14Veritas In Silico to Announce FY2024 Financial Results on February 13
- 2025.01.08(Report) Representative Nakamura Delivers a Lecture at the Chemistry Committee Joint Meeting of the Science Council of Japan
- 2024.11.29(Report) Veritas In Silico participate in the 41st Medicinal Chemistry Symposium
- 2024.11.12(Report) CSO’s talk in the Company Presentations session at BIO-Europe 2024
- 2024.10.24Veritas In Silico Inc. to Announce Third Quarter Fiscal Year 2024 Financial Results on November 13
- 2024.10.18(Scheduled for Nov. 4) CSO to present in the Company Presentations session at BIO Europe 2024
- 2024.10.17(Report) “Japan Healthcare Venture Summit 2024” hosted by the Ministry of Health, Labour and Welfare
- 2024.10.16Veritas In Silico to participate in the 41st Medicinal Chemistry Symposium for invited lecture, poster discussion, and company exhibition
- 2024.10.04(Scheduled for Oct. 29) Senior Investigator to Present at CBI Annual Meeting 2024
- 2024.09.05(Report) Representative Nakamura present at “JASIS Collaboration – Public Utilization Platform Brings Innovation to Research” hosted by MEXT
- 2024.08.21CEO Nakamura to present at “JASIS Collaboration; Public utilization platform brings innovation to research ~Measurement and analysis systems open up new research horizons~” hosted by MEXT on Sep. 4
- 2024.08.15Announcement of Participation in “Japan Healthcare Venture Summit 2024”
- 2024.06.19Veritas In Silico Announces Milestone Achievement in Collaborative Research with Takeda
- 2024.03.12Senior investigator to present at a webinar series hosted by Oncodesign Services on March 27
- 2024.03.01New publication on the applications of artificial intelligence in RNA-targeted small molecule drug discovery
- 2024.02.08Veritas In Silico Listed on the Growth Market of the Tokyo Stock Exchange
- 2023.12.21RaQualia Pharma and Veritas In Silico announce that both companies have achieved the milestone in a joint research collaboration for mRNA-targeted small molecule drug discovery
